These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1789997)

  • 1. Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from post-ischemic acute renal failure in vivo.
    Berti F; Rossoni G; Bianchi G; Alberico P; Tettamanti R; Calvani AB; Mantovani M; Prino G
    Eicosanoids; 1991; 4(4):209-15. PubMed ID: 1789997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury.
    Hohlfeld T; Strobach H; Schrör K
    J Pharmacol Exp Ther; 1993 Jan; 264(1):397-405. PubMed ID: 8423539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin and the mechanism of action of defibrotide.
    Gryglewski RJ; Marcinkiewicz E; Radomski M; Swies J
    Eicosanoids; 1989; 2(3):163-7. PubMed ID: 2517030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart.
    Berti F; Rossoni G; Omini C; Folco G; Daffonchio L; Viganó T; Tondo C
    Eur J Pharmacol; 1987 Mar; 135(3):375-82. PubMed ID: 3556200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage.
    Thiemermann C; Löbel P; Schrör K
    Am J Cardiol; 1985 Dec; 56(15):978-82. PubMed ID: 3907318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement by defibrotide of prostanoid neosynthesis from arachidonic acid: an adenosine receptor-mediated effect?
    Bianchi G; Calvani AB; Mantovani M; Prino G
    Semin Thromb Hemost; 1991 Oct; 17(4):399-403. PubMed ID: 1803508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and biologic interactions of prostacyclin and platelet-activating factor in acute myocardial ischemia in the perfused rabbit heart.
    Berti F; Magni F; Rossoni G; De Angelis L; Galli G
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):727-32. PubMed ID: 1703593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin release from endothelial cells, induced by defibrotide treatment, favours the function of grafted rat hearts and kidneys.
    Ferrero ME; Marni A; Salari PC; Spaggiari PG; Gaja G
    Int J Tissue React; 1991; 13(4):215-8. PubMed ID: 1821415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial protection by defibrotide--a new strategy for treatment of myocardial infarction?
    Schrör K; Ackermann G; Hohlfeld T; Löbel P; Ney P; Schröder H; Strobach H
    Z Kardiol; 1989; 78 Suppl 6():35-41. PubMed ID: 2559554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of prostacyclin synthesis by defibrotide: improved contractile recovery from myocardial "stunning".
    Hohlfeld T; Strobach H; Schrör K
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):108-15. PubMed ID: 1708043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of defibrotide in endothelial cell protection.
    Corsi M; Parise M; Gaja G; Ferrero ME
    Int J Tissue React; 1993; 15(4):157-61. PubMed ID: 8188455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defibrotide has antiischemic activity in perfused rabbit hearts, preventing tissue Ca++ overloading.
    Berti F; Rossoni G; Galli G; Magni F; Mantovani M; Calvani AB; Porta R; Prino G
    Thromb Res; 1992 Jan; 65(1):13-26. PubMed ID: 1604439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of vascular prostacyclin and inhibition of platelet function by oral defibrotide in cholesterol-fed rabbits.
    Löbel P; Schrör K
    Atherosclerosis; 1989 Nov; 80(1):69-79. PubMed ID: 2513813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):679-86. PubMed ID: 3063971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by defibrotide in the platelet perfused heart.
    Löbel P; Schrör K
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):125-30. PubMed ID: 3937058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are increased ATP blood levels responsible for PGI2 release from endothelium?
    Salari PC; Marni A; Parisé M; Calvani AB; Spaggiari PG; Gaja G; Ferrero ME
    Int J Tissue React; 1991; 13(4):219-23. PubMed ID: 1668237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defibrotide, a prostacyclin releasing agent, protects the rabbit kidney from acute failure.
    Bianchi G; Alberico P; Tettamanti R; Mantovani M; Prino G; Rossoni G; Berti F
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():711-4. PubMed ID: 1825401
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in platelet reactivity, prostacyclin and thromboxane production after long-term oral defibrotide in healthy and atherosclerotic rabbits.
    Löbel P; Palmér M; Schrör K
    Prog Clin Biol Res; 1987; 242():265-70. PubMed ID: 3313414
    [No Abstract]   [Full Text] [Related]  

  • 19. Nafazatrom (BAY g 6575), a potent stimulator of prostacyclin release from cardiac and renal vessel wall.
    Klitzke AK
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):220-8. PubMed ID: 6391401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrotide, a stimulator of prostacyclin (PGI2) production, prevents the effects of ischaemic damage.
    Ferrero ME; Marni A; Rovati M; Aimini R; Salari PC; Gaja G
    Int J Tissue React; 1989; 11(4):179-84. PubMed ID: 2517498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.